Astute Medical Receives $40,400,000 Series C Funding

  • Feed Type
  • Date
    6/7/2012
  • Company Name
    Astute Medical
  • Mailing Address
    3550 General Atomics Court MS 02/641 San Diego, CA 92121
  • Company Description
    Astute Medical’s mission is to identify and validate protein biomarkers of severe acute disease.Our focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Our emphasis is on patients who present to the emergency department with acute symptoms and hospitalized patients who are at risk for an acute event.
  • Website
    http://www.astutemedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,400,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The Company intends to use the proceeds to begin commercializing its first product, as well as to advance and expand its research, development and validation of biomarker-based laboratory tests.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    De Novo Ventures
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    Domain Associates
  • Venture Investor
    Johnson & Johnson Development Corporation